Broadwood Partners and its affiliates issued the following letter to the Board of Directors of STAAR Surgical Company (STAA). Broadwood, which owns 27.5% of STAAR’s outstanding common shares, urges its fellow shareholders to vote on its GREEN Proxy Card “AGAINST” the proposed acquisition of STAAR by Alcon Inc. (ALC) on the terms announced on August 5, 2025.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STAA:
- Staar Surgical says no acquisition proposals received except from Alcon
- Broadwood: Proxy advisory firms recommend Staar shareholders vote against sale
- STAAR Surgical Faces Legal Challenges in Alcon Merger
- Broadwood issues letter to Staar Surgical board questioning ‘rush’ in Alcon sale
- Staar Surgical board reiterates support of Alcon merger agreement